Risk Assessment and Treat Compliance in Hypertension Education Trial

Not Applicable

Completed

• Conditions: Hypertension; Dyslipidemia
• Interventions: Behavioral: Knowledge of Cardiovascular Risk Assessment

• Registration Number: NCT00694239
• Lead Sponsor: Lawson Health Research Institute

Brief Summary

The RATCHET study assesses if patient knowledge of estimated cardiovascular risk at current and recommended target blood pressure levels improves compliance in the management of hypertension.

Detailed Description

Not available

Study Timeline

• Study Start: 2007-05
• Study First Submitted: 2008-06-06
• Study First Submitted QC: 2008-06-06
• Study First Posted: 2008-06-10
• Primary Completion: 2011-03
• Study Completion: 2011-03
• Status Verified: 2011-06
• Last Update Submitted: 2011-06-29
• Last Update Posted: 2011-06-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Essential hypertension (new diagnosis or established diagnosis) meeting criteria for pharmacologic therapy as defined by current guidelines

Exclusion Criteria

• Lack of written informed consent
• Previous myocardial infarction
• Previous stroke
• Congestive heart failure
• Stage 3 or greater chronic kidney disease
• Pregnancy
• Usage of medication bubble/blister package

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
A	Knowledge of Cardiovascular Risk Assessment	Risk Assessment plus standard care

Primary Outcome Measures

Name	Time	Method
Medication Compliance	1 year

Secondary Outcome Measures

Name	Time	Method
Patient perception of cardiovascular risk	1 year
Pilot Feasibility Study	1 year
Blood Pressure	1 year
Cholesterol Level	1 year
Framingham Risk Score (stroke and coronary artery disease)	1 year

Trial Locations

Locations (1)

University of Western Ontario; 🇨🇦 London, Ontario, Canada